A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

402

Participants

Timeline

Start Date

June 21, 2024

Primary Completion Date

September 1, 2025

Study Completion Date

December 15, 2025

Conditions
Hypercholesterolemia
Interventions
DRUG

Inclisiran sodium

300 mg s.c. administered at day 1 and day 90

DRUG

BPA

180 mg daily per oral

Trial Locations (54)

10367

Novartis Investigative Site, Berlin

13347

Novartis Investigative Site, Berlin

13353

Novartis Investigative Site, Berlin

14471

Novartis Investigative Site, Potsdam

14612

Novartis Investigative Site, Falkensee

15562

Novartis Investigative Site, Rüdersdorf

21109

Novartis Investigative Site, Hamburg

22041

Novartis Investigative Site, Hamburg

22607

Novartis Investigative Site, Hamburg

24105

Novartis Investigative Site, Kiel

26871

Novartis Investigative Site, Papenburg

28277

Novartis Investigative Site, Bremen

32545

Novartis Investigative Site, Bad Oeynhausen

32584

Novartis Investigative Site, Löhne

34121

Novartis Investigative Site, Kassel

37075

Novartis Investigative Site, Göttingen

39120

Novartis Investigative Site, Magdeburg

44789

Novartis Investigative Site, Bochum

44791

Novartis Investigative Site, Bochum

45147

Novartis Investigative Site, Essen

45355

Novartis Investigative Site, Essen

Novartis Investigative Site, Essen

45968

Novartis Investigative Site, Gladbeck

48149

Novartis Investigative Site, Münster

50733

Novartis Investigative Site, Cologne

52074

Novartis Investigative Site, Aachen

60389

Novartis Investigative Site, Frankfurt am Main

60590

Novartis Investigative Site, Frankfurt am Main

60594

Novartis Investigative Site, Frankfurt am Main

61348

Novartis Investigative Site, Bad Homburg

63065

Novartis Investigative Site, Offenbach

66333

Novartis Investigative Site, Völklingen

66386

Novartis Investigative Site, Saint Ingbert Oberwuerzbach

67067

Novartis Investigative Site, Ludwigshafen

67655

Novartis Investigative Site, Kaiserslautern

68305

Novartis Investigative Site, Mannheim

70376

Novartis Investigative Site, Stuttgart

79189

Novartis Investigative Site, Bad Krozingen

84453

Novartis Investigative Site, Muehldorf Am Inn

89077

Novartis Investigative Site, Ulm

92237

Novartis Investigative Site, Sulzbach-Rosenberg

93053

Novartis Investigative Site, Regensburg

96049

Novartis Investigative Site, Bamberg

96215

Novartis Investigative Site, Lichtenfels

99097

Novartis Investigative Site, Erfurt

01099

Novartis Investigative Site, Dresden

04209

Novartis Investigative Site, Leipzig

06846

Novartis Investigative Site, Dessau

01307

Novartis Investigative Site, Dresden

02977

Novartis Investigative Site, Hoyerswerda

07740

Novartis Investigative Site, Jena

04416

Novartis Investigative Site, Markkleeberg

01662

Novartis Investigative Site, Meissen

01796

Novartis Investigative Site, Pirna

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY